Extract from the Register of European Patents

EP Citations: EP3071205

Cited inSearch
Type:Patent literature
Publication No.:WO2004085401  [X]
 (PFIZER PROD INC [US], et al) [X] 1-15 * page 80 - page 81; examples 170-409; claims 1, 5, 10 *;
Type:Patent literature
Publication No.:WO2011054848  [A]
 (GLAXOSMITHKLINE LLC [US], et al) [A] 1-15* claims 1, 25, 32 *
Cited inInternational search
Type:Patent literature
Publication No.:US7101869  [A]
 (BLUMENKOPF TODD A [US], et al);
Type:Patent literature
Publication No.:US2010179325  [A]
 (SUZUKI RYO [JP], et al);
Type:Patent literature
Publication No.:US2010267672  [A]
 (JUNG KYUNG-YUN [KR], et al)
Cited inby applicant
Type:Patent literature
Publication No.:US5262564  
Type:Patent literature
Publication No.:WO2004085401  
Type:Patent literature
Publication No.:WO2011054848  
Type:Non-patent literature
Publication information:   - MULLER, S.; FILIPPAKOPOULOS, P.; KNAPP, S., "Bromodomains as therapeutic targets", Expert Rev. Mol. Med., (20110000), vol. 13, doi:doi:10.1017/s1462399411001992, page e29, XP002670944
DOI: http://dx.doi.org/10.1017/s1462399411001992
Type:Non-patent literature
Publication information:   - NICODEME et al., Nature, (20100000), vol. 468, page 1119
Type:Non-patent literature
Publication information:   - DHALLUIN C.; CARLSON J.E.; ZENG L.; HE C.; AGGARWAL A.K.; ZHOU M.M., "Structure and ligand of a histone acetyltransferase bromodomain", Nature, (19990000), vol. 399, pages 491 - 6
Type:Non-patent literature
Publication information:   - CRAWFORD, N.P; ALSARRAJ, J.; LUKES, L.; WALKER, R.C.; OFFICEWALA, J.S.; YANG, H.H.; LEE, M.P.; OZATO, K.; HUNTER, K.W., "Bromodomain 4 Activation Predicts Breast Cancer Survival", Proc. Natl. Acad. Sci. USA., (20080000), vol. 105, no. 17, pages 6380 - 6385
Type:Non-patent literature
Publication information:   - GUO, N.; FALLER, D.V.; DENIS, G.V., "Activation-Induced Nuclear Translocation of RING3", J. Cell Sci., (20010000), vol. 113, no. 17, pages 3085 - 3091
Type:Non-patent literature
Publication information:   - DELMORE J.E.; ISSA G.C.; LEMIEUX M.E.; RAHL, P.B.; SHI J.; JACOBS H.M., "BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc", Cell, (20110000), vol. 146, doi:doi:10.1016/j.cell.2011.08.017, pages 904 - 17, XP028295705
DOI: http://dx.doi.org/10.1016/j.cell.2011.08.017
Type:Non-patent literature
Publication information:   - DAWSON, M. A; PRINJHA, R.K.; DITTMAN, A.; GIOTOPOULOS, G.; BANTCHEFF, M.; CHAN, W-I.; ROBSON, S.C.; CHUNG, C.; HOPF, C.; SAVITSKI,, "Inhibition of BET recruitment of chromatin as an effective treatment of MLL-fusion leukemia", Nature, (20110000), vol. 0, pages 1 - 5
Type:Non-patent literature
Publication information:   - PICAUD, S.; DA COSTA, D.; THANASOPOULOU, A.; FILIPPAKOPOULOS, P.; FISH, P.; PHILPOTT, M.; FEDEROV, O.; BRENNAN, P.; BUNNAGE, M. E., "PFI-1 - A highly Selective Protein Interaction Inhibitor Targeting BET Bromodomains", Cancer Res., (20130000), vol. 73, no. 11, doi:doi:10.1158/0008-5472.CAN-12-3292, pages 3336 - 3346, XP055130754
DOI: http://dx.doi.org/10.1158/0008-5472.CAN-12-3292
Type:Non-patent literature
Publication information:   - S. BERGE et al., Journal of Pharmaceutical Sciences, (19770000), vol. 66, no. 1, pages 1 - 19
Type:Non-patent literature
Publication information:   - P. GOULD, International J. of Pharmaceutics, (19860000), vol. 33, pages 201 - 217
Type:Non-patent literature
Publication information:   - The Orange Book, Food & Drug Administration